Latest Strategy News

European Lithium Limited signals a likely change to the timetable for its replacement options offer as 208 million options approach expiry in November. Investors await updated details amid potential capital structure implications.

EMVision Medical Devices’ latest Share Purchase Plan has attracted applications exceeding its initial $1 million target, with limited oversubscription capacity remaining ahead of the October 23 closing date.

NSX Limited’s shares have been suspended from trading following Federal Court approval of its acquisition by an Ontario-based entity linked to CNSX Markets Inc. This marks a significant shift in ownership for the Australian stock exchange operator.

Alkane Resources has released its FY25 Mineral Resources and Ore Reserves update, highlighting a robust asset base across Australia and Sweden and reinforcing its growth trajectory with ongoing capital investments.

Triton Minerals advances its graphite sale resolution with NQM while initiating key field activities at the Aucu Gold-Copper Project in Mozambique, alongside launching a shareholder consolidation scheme.

Dominion Investment Group Limited has announced an offer of up to $500 million in unsecured, deferrable, redeemable floating rate notes, aiming to provide investors with monthly income and ASX listing under ticker DMNHA.

VHM Limited has significantly expanded its Exploration Target at the Goschen Project in Victoria, revealing a potential resource of up to 4 billion tonnes of ore rich in valuable heavy minerals and rare earths. This update underscores Goschen's emerging status as a major player in Australia's mineral sands sector.

QBE Insurance Group has announced the redemption of its USD 300 million 6.10% fixed rate subordinated notes due 2045, marking a notable step in its capital management strategy with regulatory approval secured.

Bod Science reports a $576k cash outflow in Q1 FY2026 amid ongoing administration and delays in Biortica audit completion. The company plans a shareholder vote in November to approve its acquisition of Biortica and exit from administration.

Santana Minerals reports robust assay results from its RAS North drilling program, confirming strong grade continuity and potential resource upgrades. Concurrently, the RINA drilling reveals a fertile, largely untested gold system along the Rise and Shine Shear Zone, hinting at significant regional expansion opportunities.

Regal Partners Limited reported a robust 13.1% increase in funds under management to $20 billion, driven by strong client inflows and positive investment returns. Performance fees for the second half of 2025 are tracking well above broker expectations, signaling strong momentum.

Aureka Limited has reported its highest-grade gold assay to date at the Irvine Gold Project, with a spectacular 183 grams per tonne intercept confirming the potential for significant resource expansion.